Skip to main content
Clinical Trials/NCT06321367
NCT06321367
Completed
Not Applicable

Construction and Validation of a Predictive Model of Coinfections in Elderly COVID-19 Patients After Abandoning Zero Policy

Xiangya Hospital of Central South University1 site in 1 country1,000 target enrollmentDecember 20, 2022
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Xiangya Hospital of Central South University
Enrollment
1000
Locations
1
Primary Endpoint
Coinfection
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to learn about the clinical characteristics and construction of a predictive model in elderly COVID-19 patients. The main question it aims to answer is the main clinical characteristics and risk factors of elderly COVID-19 patients. Participants will not be asked to do any other intervening measure.

Registry
clinicaltrials.gov
Start Date
December 20, 2022
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Xiangya Hospital of Central South University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 65 years old;
  • COVID-19 was diagnosed with SARS-CoV-2 reverse transcription-polymerase chain reaction positive or rapid antigen test positive or a clinical diagnosis made by the radiological responsible clinician based on signs, symptoms, or radiology consistent with COVID-19;
  • Hospitalization more than one day, including patients in emergency.

Exclusion Criteria

  • Age less than 65 years old;
  • Pregnancy;
  • Hospitalization less than one day;
  • Outpatients;
  • Patients with missing or incomplete information.

Outcomes

Primary Outcomes

Coinfection

Time Frame: from admission to 7 days after admission

The investigators defined coinfection as coinfected bacteria, fungi, or other viruses with SARS-CoV-2 that occurred from admission to 7 days after admission. If a diagnosis was at the time of or within the first 48 hours of COVID-19 hospital admission, these infections were defined as community-acquired infections. If diagnosis occurred ≥48 hours to 7 days after admission for COVID-19, these infections were defined as early-onset hospital-acquired infections.

Study Sites (1)

Loading locations...

Similar Trials